TAKE Solutions Ltd, a globally recognized domain intensive services provider in Life Sciences, announced its financial results for Quarter and Half-Year ending 30th September 2018. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Led by a team of industry stalwarts and domain experts, TAKE has been growing steadily with FY18 revenues touching 1587.2 crores, (USD 246 Mn). The company reported net profit of 60.8 crores, growing at 65.68% as against 36.7 crores in the year-ago period.

Key Highlights from this quarter of Take Solutions:

Gartner recognized TAKE Solutions amongst Top 20 Global Solution Providers in its Market Guide for Track-and-Trace and Serialization Software Providers for Life Sciences Companies Regulatory, clinical trials, Research & Development Awards and recognition

Winner of the Golden Peacock Award for Excellence in Corporate Governance 2018.

Increasing Traction in Consulting Business both in terms of Volume and Size

Stock witnessed gap up opening today and sustains with the gains of around 6.5%. Backed by the pressure in benchmark indices, Stock has witnessed selling pressure that has led stock towards the decline of 50% in recent couple of months. Bounce back is seen in the recent past days from strong support zone. This support confluence of Monthly Ichimoku cloud levels with the support trend-line. However, Momentum indicator readings has eased off as RSI dips to previously tested levels and DI lines on meet just above neutral zone shows higher probability of bottom formation at place. Thus this opportunity can be used as low risk investment. 176-180 zone will act as Immediate resistance while crossing above which will open room towards 220-224 levels.